Germany: Facilitation In The Application Process For Medical Use Of Cannabis

Jim Finnel

Fallen Cannabis Warrior & Ex News Moderator
On 19 March Sabine Baetzing, Drug Commissioner of the federal government, Dr Harald Terpe, speaker on drug politics of the Green Party in the Bundestag, and members of staff of the Federal Institute for Pharmaceuticals and Medical Products of the Health Ministry discussed several aspects of the current application process for obtaining approval for exemption for the medical use of cannabis. There was agreement that the currently used term "medical expert opinion," that patients have to provide as a prerequisite for an exemption could be misunderstood. Rather, it requires a statement ("epicrisis") of the treating physician, by which the necessity of a treatment with cannabis is substantiated. This statement may not cover more than one typewritten page.

The Federal Institute for Pharmaceuticals and Medical Products assured to dispel unsubstantiated fears of physicians and patients concerning the prerequisites for the grant of an approval by explicit clarification of the necessary application documents. They also intended to inform physicians more effectively. Since most physicians fail to support patients in their application process due to the associated work load, this clarification could be interpreted as a facilitation, which could pave the way to a treatment with cannabis to more patients.



News Hawk: User: 420 MAGAZINE ® - Medical Marijuana Publication & Social Networking
Source: ENCOD
Copyright: 2008 European Coalition for Just and Effective Drug Policies
Contact: Encod.org
Website: IACM BULLETIN - Encod.org
 
Back
Top Bottom